Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3699483017 | Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3699484011 | Belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
1202541015 | Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg tablet (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1215444011 | Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg tablet | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1478597015 | Belladonna alkaloids+ergotamine tartrate+phenobarbital 0.2mg/0.6mg/40mg tablet | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
3490416017 | Product containing belladonna alkaloids 0.2 mg and ergotamine tartrate 0.6 mg and phenobarbital 40 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3494216010 | Product containing belladonna alkaloids 0.2 mg and ergotamine tartrate 0.6 mg and phenobarbital 40 mg/1 each oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3501613015 | Belladonna alkaloids 0.2 mg and ergotamine tartrate 0.6 mg and phenobarbital 40 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3569171016 | Product containing only belladonna alkaloids 0.2 mg and ergotamine tartrate 0.6 mg and phenobarbital 40 mg/1 each oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3569172011 | Product containing only belladonna alkaloids 0.2 mg and ergotamine tartrate 0.6 mg and phenobarbital 40 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3699482010 | Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3699483017 | Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3699484011 | Belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing belladonna | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing ergotamine (medicinal product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing phenobarbital (medicinal product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Oral phenobarbital | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Psychotherapeutic agent | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Naturally occurring alkaloid (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Phenobarbital (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Ergotamine (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing belladonna alkaloids and ergotamine tartrate and phenobarbital | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Barbiturate antiepileptic | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Ergotamine tartrate (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Belladonna (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Analgesic (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Psychotherapeutic agent | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet (dose form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing ergotamine tartrate in oral dosage form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing belladonna in oral dosage form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Phenobarbital-containing product in oral dose form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Belladonna alkaloids - chemical (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Ergotamine tartrate (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mg | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mg | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Phenobarbital (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Phenobarbital (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 40 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Belladonna (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Belladonna (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 0.2 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Ergotamine tartrate (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Ergotamine tartrate (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 0.6 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Phenobarbital (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 40 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Ergotamine tartrate (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Belladonna alkaloids - chemical (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Belladonna alkaloids - chemical (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Phenobarbital (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | trois | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mcg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mcg | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 600 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mcg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Ergotamine tartrate (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 3 | |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Phenobarbital (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets